For research use only. Not for therapeutic Use.
Yonkenafil hydrochloride（Cat No.:I010128）is an investigational compound being developed for the treatment of erectile dysfunction (ED). It is a potent selective inhibitor of phosphodiesterase type 5 (PDE5), an enzyme that regulates blood flow in the penis. By inhibiting PDE5, Yonkenafil hydrochloride helps to relax the smooth muscle and enhance blood flow to the area, promoting and sustaining an erection in response to sexual stimulation. Preclinical and early clinical studies have shown promising results, with ongoing trials focused on assessing its safety, efficacy, and potential as an alternative to existing ED treatments.
| CAS Number | 804519-64-0 |
| Synonyms | 2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-pyrrolo[2,3-d]pyrimidin-4-one;hydrochloride |
| Molecular Formula | C24H34ClN5O4S |
| Purity | ≥95% |
| IUPAC Name | 2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-pyrrolo[2,3-d]pyrimidin-4-one;hydrochloride |
| InChI | InChI=1S/C24H33N5O4S.ClH/c1-5-10-28-16-17(4)21-23(28)25-22(26-24(21)30)19-15-18(8-9-20(19)33-7-3)34(31,32)29-13-11-27(6-2)12-14-29;/h8-9,15-16H,5-7,10-14H2,1-4H3,(H,25,26,30);1H |
| InChIKey | CDCLCASCGRHUNT-UHFFFAOYSA-N |
| SMILES | CCCN1C=C(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C.Cl |
